Why merge when you can shuffle money at will !!!!
When having chairman and directors in common becomes murky!!!
" All cash payments to initiate the licence agreement will be funded through Imugene’s existing cash reserves with the option to make some payments in Imugene equity, should Imugene elect to do so. Imugene will pay an introduction fee of US$3 million to Chimeric Therapeutics Limited in connection with the transaction."
As CHM holder I should be happy but this sort of conduct doesn't sit well with me.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |